Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UBTFL7 (Upstream binding transcription factor, RNA polymerase I-like 7) is a human pseudogene, meaning it is a DNA sequence closely related to a protein-coding gene, but lacking functional protein expression due to disabling mutations or regulatory limitations[6][7][9]. It is related to the upstream binding transcription factor family, whose canonical member UBTF plays a crucial role in ribosomal RNA transcription and chromatin remodeling[3][5]. Pseudogenes like UBTFL7 may have non-coding functions, such as acting as competitive endogenous RNAs (ceRNAs) or miRNA decoys, but specific biological or disease roles for UBTFL7 have not been established[8]. UBTFL7 is not recognized as a therapeutic target or biomarker and is typically cataloged for genome annotation purposes only[4][6][7][9].
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Upstream binding transcription factor, RNA polymerase I-like 7 (pseudogene) (UBTFL7).